Sponsor or institution
Clinical trials and research at Providence Health & Services
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Providence Health & Services that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CAN1012 injection before surgery for DCIS or LCIS | Phase 1 | Portland, Oregon | Recruiting | Feb 13, 2026 |
| Testing M3T01 alone and with pembrolizumab or standard chemotherapies for advanced solid tumors | Phase 1 | Portland, Oregon | Recruiting | Dec 5, 2024 |
| Combination of INBRX-106 and Pembrolizumab for Treating Stage II Triple Negative Breast Cancer | Phase 2 | Los Angeles, California and 2 other locations | Recruiting | Apr 9, 2024 |
| Using obinutuzumab to maintain response in patients with central nervous system lymphoma | Phase 2 | New York, New York and 6 other locations | Recruiting | Dec 18, 2023 |
All recruiting trials (4)
-
CAN1012 injection before surgery for DCIS or LCIS
A phase 1 study tests CAN1012 injected into the lesion of patients with DCIS or LCIS to see if it is safe before they have planned surgery.
-
Testing M3T01 alone and with pembrolizumab or standard chemotherapies for advanced solid tumors
This trial tests whether the antibody M3T01, by itself or with pembrolizumab or standard chemotherapies, is safe and might help adults with metastatic or unresectable solid tumors.
-
Combination of INBRX-106 and Pembrolizumab for Treating Stage II Triple Negative Breast Cancer
This study is testing a new combination of two drugs, INBRX-106 and pembrolizumab, to see if it can help people with Stage II Triple Negative Breast Cancer avoid chemotherapy.
-
Using obinutuzumab to maintain response in patients with central nervous system lymphoma
This study is testing if a medication called obinutuzumab can help people with central nervous system lymphoma stay in remission longer after their initial treatment.
Quick answers
How many clinical trials run by Providence Health & Services are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.